Expert Committee, ‘We accepts importance of creating legal bases for off-label uses’

Importance of creating a revision bill to the Pharmaceutical Affairs Law, which create a base to evaluate safety and efficacy about off-label use of pharmaceutical drugs, was accepted.

Young-Hwan Seok, a senior expert member at the Health and Welfare Committee, revealed a review report of the partial revision bill to the Pharmaceutical Affairs Law that was recently tabled by the Ministry of Fo...